Vivanza Biosciences Share Price
13 Nov, 2026 4:01 PM (IST)
Vivanza Biosciences Performance
- Today's Low
- ₹1
- Today's High
- ₹2
- 52 Week Low
- ₹1
- 52 Week High
- ₹3
- Open Price₹2
- Previous Close₹2
- Volume29,608
- 50 DMA₹1.60
- 100 DMA₹1.70
- 200 DMA₹1.90
Vivanza Biosciences Chart
Investment Returns
- Over 1 Month -14.97%
- Over 3 Month -28.64%
- Over 6 Month -23.24%
- Over 1 Year -40.34%
Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!
Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 205.8
- PEG Ratio
- 1.9
- Market Cap Cr
- 6
- P/B Ratio
- 1.3
- Average True Range
- 0.1
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -0.1
- RSI
- 40.28
- MFI
- 23.97
Latest Stock News Updates
in terms of Regulation 47 of the SEBI(LODR) Reg, 2015 please find copy of the newspaper publication in the English and vernacular language of the state, wherein the Unaudited Standalone and Consolidated financial Statements for the Quarter ended September 30, 2026 published.
- BSE India
- 1 week ago
Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Friday, 06th November, 2026, at the Registered Office of the Company, has inter alia considered and approved the following businesses: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended on 30th September, 2026, together with the Limited Review Report (Annexure -A). 2. Any other business with the permission of the Chair.
- BSE India
- 1 week ago
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter and Half year ended September 30, 2026 and Any other business with the permission of the chair
- BSE India
- 1 week 3 days ago
Vivanza Biosciences Financials
Vivanza Biosciences Technicals
EMA & SMA
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹1.50
- 50 Day
- ₹1.60
- 100 Day
- ₹1.70
- 200 Day
- ₹1.90
Resistance and Support
- R3 1.60
- R2 1.50
- R1 1.50
- S1 1.40
- S2 1.30
- S3 1.30
Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-06 | Quarterly Results | (Revised) |
| 2026-08-17 | Others | |
| 2026-08-07 | Quarterly Results | (Revised) |
| 2026-06-18 | Others | Inter-alia, to consider 1. Approve appointment of Mr. Hemant Amrish Parikh as a Non-Executive Non-Independent Director. 2. Approve the transfer of certain unverified shares. 3. Other business matters. |
| 2026-05-07 | Audited Results | (Revised) |
About Vivanza Biosciences
Vivanza Biosciences engaged in the Pharmaceuticals and Agro Trading & Consultancy Activities business with a focus on delivering quality healthcare products and solutions. View More- NSE Symbol
- VIVANZA
- BSE Symbol
- 530057
- ISIN
- INE984E01035
Similar Stocks to Vivanza Biosciences
Popular Stocks
Vivanza Biosciences FAQs
Vivanza Biosciences share price is ₹1 As on 14 November, 2026 | 11:57
The Market Cap of Vivanza Biosciences is ₹5.7 Cr As on 14 November, 2026 | 11:57
The P/E ratio of Vivanza Biosciences is 205.8 As on 14 November, 2026 | 11:57
The PB ratio of Vivanza Biosciences is 1.3 As on 14 November, 2026 | 11:57
The 52 week High & Low of Vivanza Biosciences is ₹2.7/₹1.3 respectively As on 14 November, 2026 | 11:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.